Table 2.
Multivariate Regression Models* Relating Intensity of Antiglycemic Medication Therapy to Glycemic Control
Change in HbA1c | Outcome HbA1c>8% | |||
---|---|---|---|---|
Variable | Coefficient | p-Value | Odds Ratio | 95% CI |
Intensity of therapy (per increase of 0.1) | −0.064 | <.0001 | 0.91 | 0.88, 0.98 |
Index visit HbA1c | — | — | 1.76 | 1.72, 1.81 |
Age (per increase of 10 years) | 0.013 | .39 | 0.78 | 0.75, 0.81 |
Male gender | 0.147 | .13 | 1.12 | 0.86, 1.45 |
Any diabetes complication | −0.131 | <.0001 | 1.29 | 1.18, 1.41 |
Charlson index | 0.026 | .01 | 1.02 | 0.99, 1.05 |
Psychiatric diagnosis | 0.156 | .0002 | 1.03 | 0.92, 1.15 |
Alcohol/substance abuse diagnosis | −0.169 | .06 | 0.79 | 0.62, 1.00 |
Oral steroid use | −0.022 | .75 | 0.83 | 0.69, 1.00 |
A linear model was used when modeling outcome visit HbA1c minus index visit HbA1c; a negative coefficient indicates improved glycemic control. A logistic model was used to predict odds of an outcome HbA1c>8%; an odds ratio less than 1.0 indicates better control
HbA1c, hemoglobin A1c; CI, confidence interval